mRNA: A promising platform for cancer immunotherapy
Advanced Drug Delivery Reviews · 2023-08 · 199 · 114993
DOI: 10.1016/j.addr.2023.114993 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-08. Verfasst von Byoungjae Kong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Department of Ophthalmology, Jo…. Hauptthemen laut MEDLINE: COVID-19, Neoplasms. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NINDS NIH HHS, Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
- Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea; Department of Life Sciences, Korea University, Seoul 02841, Republic of Korea.
- Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; D…
- Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. Electronic address: ysyang@kist.re.kr.
Förderung
- NIDDK NIH HHS
- NINDS NIH HHS
- Ministry of Science, ICT and Future Planning
- Korea Institute of Science and Technology
- National Research Foundation of Korea
- National Institutes of Health
Zitieren
APA
Kong, B., Kim, Y., Kim, E. H., Suk, J. S., & Yang, Y. (2023). mRNA: A promising platform for cancer immunotherapy. Advanced Drug Delivery Reviews, 199, 114993. https://doi.org/10.1016/j.addr.2023.114993
Vancouver
Kong B, Kim Y, Kim EH, Suk JS, Yang Y. mRNA: A promising platform for cancer immunotherapy. Advanced Drug Delivery Reviews. 2023;199:114993. doi:10.1016/j.addr.2023.114993
BibTeX
@article{Kong2023,
author = {Kong, Byoungjae and Kim, Yelee and Kim, Eun Hye and Suk, Jung Soo and Yang, Yoosoo},
title = {mRNA: A promising platform for cancer immunotherapy},
journal = {Advanced Drug Delivery Reviews},
year = {2023},
volume = {199},
pages = {114993},
doi = {10.1016/j.addr.2023.114993}
}
EUVIMED